Vnitr Lek 2021, 67(1):16-21 | DOI: 10.36290/vnl.2021.002

Long-term ECG monitoring

Veronika Bulková
MDT - Mezinárodní centrum pro telemedicínu, Brno
Centrum kardiovaskulární péče, Neuron Medical, Brno

ECG recording represents an essential method for the diagnosis of heart rhythm disturbances. Long-term monitoring helps to identify arrhythmias that have not been detected by means of standard 12-lead ECG or 24-48 hour ECG Holter. With time, ECG monitoring facilities improve, the ECG recorders are becoming smaller, and the recording time is prolonging. At present, continuous ECG recording is generally available. Smart watches and fitness bracelets further expand monitoring options in patients with known or suspected arrhythmia. Individual type and frequency of symptoms remain the most significant criterion for the selection of suitable ECG recorder and recording time.

Keywords: long-term ecg monitoring, telemedicine.

Published: March 2, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bulková V. Long-term ECG monitoring. Vnitr Lek. 2021;67(1):16-21. doi: 10.36290/vnl.2021.002.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Brugada P, Gursoy S, Brugada J et al. Investigation of palpitations. Lancet 1993; 341: 1254-1258. Go to original source... Go to PubMed...
    2. Locati ET, Moya A, Oliveira M et al. External prolonged electrocardiogram monitoring in unexplained syncope and palpitations: results of the SYNARR‑Flash study. Europace 2016; 18: 1265-1272. Go to original source... Go to PubMed...
    3. Reiffel JA, Schulhof E, Joseph B et al. Optimum duration of transtelephonic ECG monitoring when used for transient symptomatic epizode detection. J Electrocardiol 1991; 24: 165-168. Go to original source... Go to PubMed...
    4. Brignole M. Syncope, management from emergency department to hospital. J Am Coll Cardiol 2008; 51: 284-287. Go to original source... Go to PubMed...
    5. Soteriades ES, Evans JC, Larson MG et al. Incidence and prognosis of syncope. N Engl J Med 2002; 347: 878-885. Go to original source... Go to PubMed...
    6. Middlekauff HR, Stevenson WG, Saxon LA. Prognosis after syncope: impact of left ventricular function. Am Heart J 1993; 125: 121-127. Go to original source... Go to PubMed...
    7. Brignole M, Moya A, de Lange FJ et al. 2018 ESC Guidelines of the diagnosis and management of syncope. Eur Heart J 2018; 39: 1883-1948. Go to original source... Go to PubMed...
    8. Bass EB, Curtiss EI, Arena VC et al. The duration of Holter monitoring in patients with syncope: is 24 hours enough? Arch Intern Med 1990; 150: 1073-1078. Go to original source...
    9. Linzer M, Yang EH, Estes NA. Diagnosing syncope. Part 1: Value of history, physical examination, and electrocardiography. Clinical Efficacy Assessment Project of the American College of Physicians. Ann Intern Med 1997; 126: 989-996. Go to original source... Go to PubMed...
    10. Gula LJ, Krahn AD, Massel D et al. External loop recorders: determinants of diagnostic yield in patients with syncope. Am Heart J 2004; 147: 644-648. Go to original source... Go to PubMed...
    11. Locati ET, Vecchi AM, Vargiu S et al. Role of extended external loop recorders for the diagnosis of unexplained syncope, pre‑syncope, and sustained palpitations. Europace 2014; 16: 914-922. Go to original source... Go to PubMed...
    12. Locati ET, Moya A, Oliveira M et al. External prolonged electrocardiogram monitoring in unexplained syncope and palpitations: results of the SYNARR‑Flash study. Europace 2016; 18: 1265-1272. Go to original source... Go to PubMed...
    13. Frangini P, Cechin F, Jordao L et al. How revealing are insertable loop recorders in pediatrics? Pacing Clin Electrophysiol 2008; 31: 338-343. Go to original source... Go to PubMed...
    14. Krahn AD, Klein GJ, Yee R et al. Randomized assessment of syncope trial: conventional diagnostic testing versus a prolonged monitoring strategy. Circulation 2001; 104: 46-51. Go to original source... Go to PubMed...
    15. Podoleanu C, DaCosta A, Defaye P et a. Early use of an implantable loop recorder in syncope evaluation: a randomized study in the context of the French healthcare system (FRESH study). Arch Cardiovasc Dis 2014; 107: 546-552. Go to original source... Go to PubMed...
    16. Sulke N, Sugihara C, Hong P et al. The benefit of a remotely monitored implantable loop recorder as a first line investigation in unexplained syncope: The EaSyAS II trial. Europace 2016;18: 912-991. Go to original source... Go to PubMed...
    17. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22: 983-988. Go to original source... Go to PubMed...
    18. Adams HP Jr, Biller J. Classification of subtypes of ischemic stroke: history of the trial of org 10172 in acute stroke treatment classification. Stroke 2015; 46: e114-117. Go to original source... Go to PubMed...
    19. Kirchhof P, Benussi S, Kotecha D et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC), developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC, endorsed by the European Stroke Organisation (ESO). Europace 2016; 18: 1609-1678. Go to original source... Go to PubMed...
    20. Powers WJ, Rabinstein AA, Ackerson T et al. 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke 2018; 49(3): e46-e110. Go to original source... Go to PubMed...
    21. Wein T, Lindsay MP, Cote R et al. Canadian stroke best practice recommendations:
    22. Secondary prevention of stroke, sixth edition practice guidelines, update 2017. Int J Stroke 2018; 13(4): 420-443. Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.